|
KMID : 0882420210960020085
|
|
Korean Journal of Medicine
2021 Volume.96 No. 2 p.85 ~ p.91
|
|
|
Anti-Diabetic Drugs in Cardiovascular Disease
|
|
Kim Se-Eun
Yoo Byung-Su
|
|
|
Abstract
|
|
|
|
Diabetes is one of the important risk factors in cardiovascular disease associated with atherosclerosis, and cardiovascular disease is the leading cause of death in patients with diabetes mellitus. Recent randomized placebo-controlled cardiovascular outcome trials of all new antidiabetic drugs have linked SGLT-2 inhibitors and GLP1-agonists to not only increased cardiovascular stability but significant reduction of cardiovascular disease. These results have led to preferential selection of the most effective and beneficial antidiabetic drugs with the evidence of cardiovascular safety and efficacy. Herein, we address cardiovascular stability and the effectiveness of antidiabetic drugs, focusing on recently developed ones.
|
|
|
KEYWORD
|
|
|
Anti-diabetic drugs, Safety, Cardiovascular outcomes trials
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|